جستجوی استاد راهنمای دانشگاهی

• Developmental Neurobiology
• RNA Modification
• Post-transcriptional Regulation
• +۴ مورد دیگر

Dr. Sheng-Jian Ji is a Tenured Associate Professor at the School of Life Sciences, Department of Neuroscience at Southern University of Science and Technology (SUSTech) in Shenzhen, China. He also serves as the Academic Vice President of Shude Academy and was previously the first Deputy Director of Research and Graduate Affairs in the Department of Biology at SUSTech (2016-2018). As a leading neuroscientist specializing in RNA modification and neural development, Dr. Ji has established an internationally recognized research program. Dr. Ji's educational background includes: 2003-2007: Postdoctoral Fellow, Johns Hopkins University School of Medicine, Neurobiology 1998-2003: PhD in Biochemistry and Molecular Biology, Peking University School of Life Sciences 1994-1998: Bachelor's Degree in Biochemistry, Yantai University Department of Biochemistry Dr. Ji's research primarily focuses on developmental neurobiology, with particular emphasis on post-transcriptional regulation mechanisms including RNA modification and local translation of mRNA in axons. His laboratory is recognized as one of the leading international groups studying how mRNA modification (particularly m6A and m5C) regulates neural development and function. Through innovative approaches combining molecular biology, cell biology, and microfluidic technologies, his team has revealed important insights into axon growth, dendrite maintenance, cortical neurogenesis, and retinal development. His publication record shows a clear trajectory from fundamental mechanisms of RNA modification to applications in understanding neurological disorders and aging. Recent work has expanded into aging-related neural decline, cognitive functions, and potential therapeutic targets for neurological conditions. Dr. Ji has received numerous prestigious awards: 2020, 2016: SUSTech Excellent College Mentor 2020: SUSTech Biology Department Outstanding Service Award 2019: Guangdong Province Talent Youyue Card A 2017: Guangdong Provincial Professor of Neurobiology 2013: Jiangsu Distinguished Professor (Nanjing University) 2011: National Natural Science Award Second Prize (third contributor) As an educator, Dr. Ji teaches undergraduate Neurobiology and graduate Cellular and Molecular Neurobiology courses. He actively mentors students, with recent master's graduates including Yuan Jiaxin and Zhang Pingrui. His laboratory recruits postdoctoral fellows (with salaries of 335,000+ RMB annually), research assistants, and graduate students, providing comprehensive training in molecular techniques, neuronal cell culture, microfluidics, and omics approaches. Dr. Ji leads a vibrant research team that collaborates both within SUSTech and internationally. His work continues to advance understanding of RNA modification in neural development, function, and aging, with recent progress highlighted in June 2025.

• Neurosciences
• Physiology
• Microbiology
• +۵ مورد دیگر

Professor Elisa Hill is a distinguished academic at RMIT University where she serves as a Professor in the Department of Health and Biomedical Sciences within the College of Science. She leads the Gut-Brain Axis Laboratory and holds the significant position of Deputy Chair of the Academic Board at RMIT University. Her career spans prestigious institutions including The University of Melbourne and research collaborations in Paris, France. Professor Hill earned her PhD in Neuroscience from The University of Melbourne in 2002. She subsequently undertook a CNRS postdoctoral position in Paris studying cortical neuronal diversity. Returning to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow, she joined Prof Steve Petrou's laboratory to investigate neuronal networks in genetic mouse models of epilepsy. In 2009, she imported the Neuroligin-3R451C mouse model of autism to Australia, establishing herself as a pioneer in gut-brain axis research. Her research program focuses on three interconnected areas: identifying causes of gut dysfunction in transgenic mouse models of neurological disease, determining how neurons communicate with the lymphoid system and inflammation, and understanding interactions between the nervous system and bacteria. Professor Hill has demonstrated that gene variations associated with autism alter neuron populations in the mouse enteric nervous system, affecting gut motility, permeability, microbiome composition, and behavior. Her laboratory has developed sophisticated capabilities including video-imaging assays for gut motility, immunofluorescence for neuronal and immune cell analysis, and whole-cell patch clamp electrophysiology for neuronal activity profiling. Analysis of her recent publications reveals a strong focus on the gut-brain axis in autism, with particular attention to the Neuroligin-3R451C mouse model. Her work spans neuroimmunology, gastrointestinal physiology, microbiome interactions, and behavioral neuroscience, demonstrating an increasingly interdisciplinary approach that integrates molecular, cellular, and systems-level perspectives. A notable trend is the expansion of her research into translational applications, including biomaterial development for urogynaecological health. NHMMRC Howard Florey Centenary Fellowship ARC Future Fellowship RMIT Senior Vice Chancellor's Research Fellowship Professor Hill actively supervises numerous PhD students including Vic Lin, Yuansong Li, and Mohammed Al Alamoudi, among others. Her research has been supported by major funding bodies including NHMRC, US Department of Defense CDMRP, CNRS, ARC, and RMIT. She leads the Gut-Brain Axis Laboratory, which collaborates extensively with researchers across institutions, particularly with Prof Ashley Franks at La Trobe University. The laboratory employs a multidisciplinary team with expertise in neuroscience, microbiology, immunology, and gastrointestinal physiology, utilizing advanced techniques to investigate the complex interactions between the nervous system, immune system, and gut microbiome.

Katrina Choeمشاهده پروفایل

استادیار

• Social Neuroscience
• Autism Spectrum Disorders
• Oxytocin Signaling
• +۴ مورد دیگر

Katrina Choe serves as Assistant Professor in the Department of Psychology, Neuroscience & Behaviour at McMaster University and holds a Tier 2 Canada Research Chair in Neurobiology of Social Behaviour. Her research program investigates the multi-level neurobiological mechanisms underlying psychiatric disorders, with primary focus on autism spectrum disorders (ASD) and oxytocin signaling pathways. Her academic training includes: PhD in Neuroscience from McGill University (2013) Honours BSc in Zoology from University of Toronto (2002-2006) Postdoctoral Fellowship at UCLA (2013-2020) Dr. Choe's research employs an integrative approach spanning molecular, cellular, circuit, and network levels to examine how ASD-associated gene mutations disrupt social behavior. Current work centers on oxytocin signaling mechanisms in ASD, convergent neurobiological pathways across psychiatric disorders, and the role of glial cells in neural circuit function. Her lab utilizes advanced techniques including optogenetic fMRI, single-cell RNA sequencing, and multi-level behavioral assays in genetic mouse models. Analysis of her 15 most recent publications reveals a clear research trajectory: early work (2015-2020) established foundational knowledge in vasopressin neuron regulation and salt homeostasis, while recent publications (2022-2025) demonstrate a focused shift toward ASD mechanisms, oxytocin signaling, and social circuit dysfunction using the Cntnap2 knockout model. This evolution reflects her transition from postdoctoral training to independent research leadership. Her scientific recognition includes: Tier 2 Canada Research Chair in Neurobiology of Social Behaviour (2022) NIMH K99/R00 Award CIHR Postdoctoral Fellowship Dr. Choe actively mentors six graduate students across PhD and MSc programs while leading a dynamic research team comprising postdoctoral fellows, laboratory technicians, and undergraduate researchers. Her program receives substantial support from major grants including a 5-year CIHR Project Grant and NSERC Discovery Grant focused on 'The role of CASPR2 in central oxytocin system development.' The Choe Lab maintains active collaborations with leading neuroscience groups including the Bourque, Prager-Khoutorsky, and Cunningham labs, as evidenced by participation in the 4th 1000 Islands/Gananoque Meeting on Hypothalamic Mechanisms. Her laboratory, established in 2020, operates as a multidisciplinary hub utilizing molecular biology (qPCR, RNA-seq), advanced imaging (lightsheet, confocal), electrophysiology (in vitro and in vivo), and behavioral neuroscience approaches to investigate social behavior mechanisms. Current projects examine microglia-astrocyte-neuron interactions in social circuit function and the therapeutic potential of oxytocin for ASD-related social deficits.

• Neuroscience
• Olfactory System
• Central Nervous System Development
• +۴ مورد دیگر

Charles A. Greer is Professor of Neurosurgery and Neuroscience at Yale School of Medicine, where he serves as Co-Vice Chair of Research for Neurosurgery and Director of the Yale Interdepartmental Neuroscience Graduate Program. He maintains joint appointments in both the Department of Neurosurgery and Department of Neuroscience, with additional affiliations through the Wu Tsai Institute, Yale Combined Program in the Biological and Biomedical Sciences, and Yale Stem Cell Center. Dr. Greer's research focuses on understanding the fundamental mechanisms that establish orderly topographic maps within the central nervous system during development and regeneration. His laboratory primarily investigates the complex olfactory system, studying how axons sort into functional subsets and target specific regions in the olfactory bulb. His work has significant implications for understanding neural regeneration following injury or disease, particularly through his research on ensheathing cells that support axon growth and can promote remyelination in damaged spinal cord tissue. His research spans multiple disciplines including neuroanatomy, developmental neuroscience, and neural regeneration, with particular emphasis on the molecular and cellular mechanisms of axon targeting, glial cell function, and neural circuit formation. Dr. Greer has established extensive collaborations across Yale departments including Neurology, Neurobiology, Anesthesiology, and Ophthalmology, as well as with institutions including Columbia University, Emory University, The Rockefeller University, University of Maryland, and University of Colorado. Dr. Greer has received numerous prestigious awards including the Max Mozell Award for Outstanding Achievements in the Chemical Senses, the R.H. Wright Award for Outstanding Research in Olfaction, and recognition as Distinguished Professor from Universite Pierre et Marie Curie in Paris. He has served as President of the Association for Chemoreception Sciences and as a member of NIH study sections and the Advisory Council for the National Institute on Deafness and Other Communication Disorders. As an educator, Dr. Greer has directed the Yale Interdepartmental Neuroscience Graduate Program and mentored numerous students and postdoctoral fellows. He serves as Associate Editor for The Journal of Comparative Neurology and Journal of Neuroscience, and sits on the editorial boards of several other neuroscience journals. His extensive publication record demonstrates sustained contributions to understanding the organization and development of neural systems, particularly the olfactory pathway.

Cornelius Faberمشاهده پروفایل

استاد

• MRI cell tracking
• infection imaging
• MR methodology
• +۶ مورد دیگر

Cornelius Faber is a University Professor in the Department of Radiology at the University of Münster, Germany, where he leads the Experimental Nuclear Magnetic Resonance research group. His work focuses on developing and implementing novel MRI techniques that extend the boundaries of magnetic resonance imaging in terms of spatial and temporal resolution, sensitivity, and specificity for physiological, structural, and molecular changes. He actively participates in the "Cells in Motion" interdisciplinary research initiative at the university. Professor Faber's research spans multiple critical areas in medical imaging and biomedical science. His primary expertise lies in MRI cell tracking , enabling visualization of cellular dynamics in vivo. He has made significant contributions to infection imaging , developing methods to detect and characterize microbial infections using MRI. His work on MR methodology development has advanced quantitative imaging techniques, while his research on multimodal integration in MR and MRI contrast mechanisms has provided deeper insights into molecular and cellular processes. His research bridges physics, engineering, and biomedical applications, with particular relevance to inflammation, cancer, neurological disorders, and cardiovascular disease. Analysis of Professor Faber's extensive publication record reveals a clear evolution from fundamental MRI technique development toward increasingly sophisticated applications in disease models. His recent work demonstrates a strong trend toward multimodal imaging approaches that combine MRI with complementary techniques such as mass spectrometry, optical imaging, and PET. This integration creates comprehensive diagnostic platforms that provide both anatomical and molecular information. A notable pattern is the focus on cellular dynamics, particularly immune cell behavior in inflammatory conditions and tumor microenvironments, with applications spanning neuroscience, oncology, and cardiology. Professor Faber leads a multidisciplinary research team of approximately 15 members, including scientists, doctoral students, technicians, and medical students. His laboratory is deeply integrated with the University of Münster's research infrastructure, particularly the Multiscale Imaging Centre. The group's work contributes significantly to advancing preclinical MRI methodologies while maintaining strong clinical relevance, with numerous publications in high-impact journals across medical imaging, neuroscience, and biomedical engineering disciplines.

Manoj Upadhyaمشاهده پروفایل

پژوهشگر

• Neuroscience
• Neuropharmacology
• Epilepsy Research
• +۴ مورد دیگر

Manoj Upadhya is a Postdoctoral Research Associate at the Aston School of Life and Health Sciences, Aston University (UK). His research focuses on epilepsy, neuropharmacology, and neurodegenerative diseases, with expertise in rodent models, electrophysiology, and molecular biology. He holds a PhD from RTM Nagpur University (India) and has held roles including Assistant Professor in Pharmacology and Research positions at IISER Pune and Sun Pharma. Education : PhD (Role of CART peptide in Neurodegeneration), RTM Nagpur University, 2009–2013 Research Interests : Translational epilepsy research, autoimmune encephalitis, pain mechanisms, and neurodegenerative diseases using rodent models. Techniques include behavioral paradigms, electrophysiology, and confocal imaging. Key contributions include identifying therapeutic targets for Parkinson's, Alzheimer's, and Huntington's diseases. Articles Trends : Recent work emphasizes autoimmune epilepsy mechanisms, neuroprotective therapies (e.g., AP39), and pain modulation via TRP channels. Studies utilize rodent models, monoclonal antibodies, and neurosteroid interventions. Awards : Best Publication in Peer-Reviewed Journal Category (2016) Executive Master of Business Administration (EMBA) (2015) Best Poster Award (2013) Grants & Advising : Accepting PhD students for projects like 'Brain on fire – investigating microglia in epilepsy.' Active in drug discovery collaborations, including patents for Parkinson's therapies. Labs/Teams : Maintains research collaborations with institutions like IISER Pune and the Encephalitis Society (UK). Active in professional bodies such as the Society for Neuroscience.

Karl Hemmingمشاهده پروفایل

مدرس ارشد

• Organic Chemistry
• Synthetic Organic Chemistry
• Heterocyclic Compounds
• +۳ مورد دیگر

Karl Hemming is a Senior Lecturer in Organic Chemistry at the University of Huddersfield , affiliated with the School of Applied Sciences and the Department of Physical and Life Sciences . He is a member of the Chemical Synthesis and Design Centre , with associate memberships in the Pharmacology and Therapeutics Centre and Microbial Therapeutics and Infection Control Centre . PhD supervision available External Examiner at University of Greenwich (2021–) Royal Society of Chemistry accreditation roles Research Focus: Synthesis of heterocyclic compounds (cyclopropenones, pyrrolobenzodiazepines, isoflavones) for pharmaceutical applications, emphasizing anti-inflammatory and neuroprotective properties. His work bridges organic synthesis, medicinal chemistry, and drug delivery systems. Publication Trends: 1992–2021 output spans Cycloaddition Reactions , Nitrogen Heterocycles , and Anti-inflammatory Agents , with recent emphasis on hybrid molecules combining isoflavones with benzodiazepines or sultams. Methodologies include 1,3-cycloadditions, aza-Wittig reactions, and multicomponent synthesis. External Roles: Actively involved in academic validation (Royal Society of Chemistry), peer-review for Organic Letters and Journal of Organic Chemistry , and local chemistry community leadership (Chair of Royal Society of Chemistry Huddersfield Local Section Committee).

David Kangمشاهده پروفایل

استاد

• Alzheimer's Disease
• Neurodegenerative Disorders
• Proteinopathies
• +۳ مورد دیگر

Dr. David Kang is a Professor in the Department of Pathology at Case Western Reserve University School of Medicine, holding the Howard T. Karsner Professorship in Pathology. He also serves as a VA investigator at the Louis Stokes Cleveland VA Medical Center. Dr. Kang earned his PhD in Neuroscience from UC San Diego in 1999 and has held prior academic roles at UCSD, Seoul National University, and the Byrd Alzheimer’s Institute at USF Health. His research focuses on molecular pathways underlying neurodegenerative diseases, particularly Alzheimer’s disease (AD) and related dementias (ADRDs), including Frontotemporal dementia (FTD), Amyotrophic lateral sclerosis (ALS), and Lewy body disorders (LBD). His interdisciplinary approach employs molecular, biochemical, and imaging techniques, alongside animal models (e.g., mice, C. elegans), to study proteinopathies, mitochondrial dysfunction, and autophagy defects. Key areas include APP processing, autophagy regulation, CHCHD10-mediated pathologies, and exosome-based biomarkers. His work is supported by NIH and VA grants, with a focus on translational strategies to treat or prevent ADRDs. Dr. Kang’s lab investigates mechanisms of neurotoxicity, including Aβ production, tau aggregation, and TDP-43 cytoplasmic inclusions. Recent studies explore SSH1 inhibitors, mitochondrial signaling, and exosome-derived biomarkers for early disease detection. Collaborations with institutions like USF Health and VA hospitals underscore his commitment to bridging basic science and clinical applications.

• Medicinal Chemistry
• Organic Chemistry
• Drug Discovery
• +۵ مورد دیگر

Prof. Dr. Rainer Riedl is the Head of the Competence Center for Drug Discovery and Organic & Medicinal Chemistry at the Zurich University of Applied Sciences (School of Life Sciences and Facility Management) . He leads numerous drug development projects targeting acute myeloid leukemia , Alzheimer's disease , antimicrobial resistance , and infectious diseases , with a focus on peptide therapeutics , targeted protein degradation , and structure-based drug design . His research combines medicinal chemistry and natural product-inspired design to develop antiviral agents (including against SARS-CoV-2 ), anti-inflammatory compounds , and novel antimicrobial delivery systems using extracellular vesicles . He has pioneered computational frameworks like CyBy2 for chemical data management and contributed to inhibitor development for matrix metalloproteinases and SENPs . Recent peer-reviewed publications highlight his work in drug resistance mechanisms , peptide engineering , and innovative antiviral strategies . He holds multiple international patents for CD93 inhibitors , skin cancer treatments , and antifungal compounds , reflecting translational impact of his research.

Laura Fonkenمشاهده پروفایل

دانشیار

• Neuroimmunology
• Circadian Rhythms
• Aging and Neurodegeneration
• +۵ مورد دیگر

Laura Fonken, Ph.D. is an Associate Professor of Pharmacology & Toxicology at the University of Texas at Austin's College of Pharmacy. She holds the prestigious Lonnie F. Hollingsworth, Sr. Centennial Fellowship in Pharmacy and leads an active research laboratory focused on neuroimmunology. Dr. Fonken's research broadly investigates how interactions among the immune, nervous, and endocrine systems regulate complex behavioral processes such as cognitive and mood-related behaviors. Her lab particularly focuses on two main research directions: (1) Targeting neuroinflammatory responses in the aged brain to improve cognitive function, and (2) Understanding the mechanisms by which the circadian system regulates neuroimmune function across the lifespan. Her work centers on microglia, the brain's resident immune cells, and how they shape behavior across the lifespan through endogenous factors like circadian rhythms and aging, as well as exogenous factors such as environmental pollutants, infection, and injury. Her research has identified that microglia become more reactive or 'primed' over an animal's lifespan, worsening outcomes when immune challenges are encountered. Her lab is investigating mechanisms by which Mycobacterium vaccae vaccination prevents exacerbated neuroinflammatory and behavioral deficits in aging, supported by NIH R01 AG062716. She is also examining how circadian rhythms in immune cell trafficking become disrupted with age and Alzheimer's Disease-like pathology, supported by NIH R01 AG078758. Dr. Fonken's publications reveal a strong focus on neuroimmunology, circadian biology, and aging. Her work demonstrates significant contributions to understanding sex differences in microglial function, the impact of hormonal changes on neuroinflammation, and the therapeutic potential of immunomodulation for age-related cognitive decline. Lonnie F. Hollingsworth, Sr. Centennial Fellowship in Pharmacy NIH R01 AG062716 grant NIH R01 AG078758 grant Dr. Fonken actively mentors graduate students across multiple programs, including Pharmaceutical Sciences (Division of Pharmacology & Toxicology) and Neuroscience (Institute for Neuroscience). Her lab has successfully graduated two PhD students (Dr. Kevin Sanchez and Dr. Rachel Chen in 2023) and currently mentors several graduate students including Kate Davis, Brandy Routh, Kiersten Bell, Drew Hynes, and Kate Callahan. She has successfully guided her students to win numerous prestigious awards including the CCST Science & Technology Policy Fellowship, NIH predoctoral fellowships, and national competition wins. The Fonken Lab maintains an active research presence with collaborations across disciplines and participation in major conferences including the Society for Neuroscience and the International Behavioral Neuroscience Society.

• Neuroscience
• Neurology
• Psychiatry
• +۴ مورد دیگر

Dr. Mazen Kheirbek is a Professor in Psychiatry at the University of California, San Francisco (UCSF) School of Medicine. He leads research at the Kheirbek Lab, focusing on hippocampal circuits in emotional behavior and psychiatric disorders. Education : BA (Washington University), PhD (University of Chicago), Postdoc (Columbia University) Research Interests center on: Neural circuits in anxiety and depression Hippocampal-prefrontal pathways Adult neurogenesis mechanisms Neuroplasticity in mood disorders Optogenetics and circuit mapping Translational psychiatry Publication Trends show consistent contributions to neuroscience journals, particularly in hippocampal function, neural circuits, and psychiatric disorders. His work often employs animal models and advanced imaging techniques. Scientific Awards : McKnight Foundation Memory & Cognitive Disorders Award (2020) Pew Scholar in Biomedical Sciences (2019) Klingenstein-Simons Fellowship (2019) Human Frontier Science Program Young Investigator (2019) NARSAD Young Investigator Award (2012) Grants include multiple NIH-funded projects: NIH/NIDA 1R01DA062018 (2025-2030): Dopaminergic circuits in insight learning NIH/NIMH 1R01MH136270 (2025-2030): Hippocampal stimulus processing NIH/NIDCD R01DC19813 (2021-2026): Dentate gyrus associative learning

• Autophagy
• Lysosomes
• Neuroinflammation
• +۵ مورد دیگر

Marta Lipinski is an Associate Professor in the Department of Anesthesiology at the University of Maryland School of Medicine . She is also affiliated with the Shock, Trauma and Anesthesiology Research (STAR) Center , the Center for Stem Cell Biology and Regenerative Medicine , and the Center for Biomolecular Therapeutics . Her research focuses on the role of autophagy and lysosomal function in neurotrauma and neurodegenerative diseases . PhD in Cancer Biology, MIT Postdoctoral training at Harvard Medical School Her research keywords include Autophagy , Lysosomes , Neuroinflammation , Lipid Metabolism , Traumatic Brain Injury , Spinal Cord Injury , and Brain Aging . She investigates how autophagy disruption after CNS injury contributes to neuroinflammation and neuronal death , with recent work exploring the link between TBI and late-onset neurodegeneration as well as autophagy-lipid metabolism interactions . Her collaborative network spans departments and institutions, including Junfang Wu (Anesthesiology), Eugene Koh (Orthopaedics), Maureen Kane (School of Pharmacy), and Michael Cummings (UMD College Park). Active grants include NIH R33 AG076858 and R01 NS115876 , focusing on multi-omics platforms for brain aging and autophagy modulation in TBI.

• Immunology
• T-cell Biology
• Proteomics
• +۶ مورد دیگر

Edward Jenkins is a Postdoctoral Researcher at the University of Oxford, affiliated with Balliol College. He is a member of the Davis Group, focusing on T-cell Biology and its intersections with proteomics, immunology, and cell signaling. His research spans diverse areas such as: T-cell activation mechanisms and membrane dynamics Vaccine adjuvant responses in lymph nodes CAR-T cell engineering for therapeutic specificity Proximity proteomics in inflammatory pathways Computational methods for 3D cell segmentation Recent publications highlight his work in immune receptor signaling, deubiquitinase substrate discovery, and nanoscale imaging of T-cell interactions. His studies often bridge molecular and cellular immunology with advanced imaging and computational tools, aiming to enhance cancer immunotherapy and vaccine design. Edward contributes to collaborative research within the Davis Group, utilizing techniques such as localisation microscopy and free-standing membrane platforms to investigate immune cell dynamics.

Ana Beatriz (Bia) DePaula-Silvaمشاهده پروفایل

استادیار

• Neurovirology
• Neurobiology
• Neuroinflammation
• +۶ مورد دیگر

Ana Beatriz (Bia) DePaula-Silva is an Assistant Professor in the Department of Pharmacology & Toxicology at the University of Utah. Her research bridges neurovirology, neurobiology, and immunology, focusing on viral-host interactions in neuroinflammatory and neurodegenerative diseases. She is affiliated with the Molecular Biology and Biological Chemistry programs. Academic Rank: Assistant Professor University: University of Utah Department: Pharmacology & Toxicology Affiliated Programs: Molecular Biology Program, Biological Chemistry Program Research Interests: Dr. DePaula-Silva investigates how central nervous system (CNS) viral infections trigger neuroinflammation and contribute to disorders like epilepsy and multiple sclerosis (MS). Her work emphasizes the role of infiltrating immune cells (e.g., macrophages) in altering neuronal excitability and inducing seizures (Program 1) and studying CD8+ T cells in axonal damage/demyelination using a TMEV-IDD mouse model of MS (Program 2). Recent Publications: Her studies highlight mechanisms linking inflammation to epilepsy and MS progression, utilizing advanced mouse models (TMEV, TMEV-IDD) to dissect immune cell contributions. Key themes include microglia-macrophage dynamics, viral pathogenesis, and transcriptional profiling during neuroinflammation.

Alex Tangمشاهده پروفایل

مدرس ارشد

• Neuroscience
• Neuroplasticity
• Aging Neuroscience
• +۴ مورد دیگر

Dr. Alex Tang is a Senior Lecturer and Senior Research Fellow at the School of Biomedical Sciences (Pharmacology and Toxicology), University of Western Australia. He holds the inaugural Sarich Family Research Fellowship and founded the Healthy Brain Ageing and Repair Lab at UWA and the Perron Institute. His research focuses on understanding age-related neurological functions and disorders, particularly stroke, aiming to develop interventions for healthy brain ageing. Tang completed his PhD in neuroscience at UWA and conducted postdoctoral research at the Okinawa Institute of Science and Technology. He has received multiple awards, including the Masao Ito Award (2018) and WA Young Achiever of the Year (2016). Education: PhD in Neuroscience, University of Western Australia Postdoctoral Research, Okinawa Institute of Science and Technology (Japan) Research Interests: His lab investigates the impact of ageing on learning, memory, and neurological disorders using techniques like transcranial magnetic stimulation (TMS) and transcranial alternating current stimulation (tACS). Key areas include neuroplasticity mechanisms, stroke recovery, and developing non-invasive brain stimulation therapies. Recent Articles: Recent work includes studies on bifocal tACS improving bimanual dexterity and interhemispheric inhibition (2025), subthreshold rTMS-induced neural plasticity (2025), and axonal remodeling post-stroke (2025). These highlight his focus on innovative stimulation techniques and their applications in aging neuroscience. Awards: Masao Ito Award (2018) Early Career Research Award (2022) WA Premier's Awards Finalist (2021) Grants & Activities: He leads grants such as WA Near Miss Awards Ideas (2025) and collaborates on pediatric audiological equipment projects. He serves on editorial boards for Frontiers in Neuroscience journals and is a member of the Australian Brain Alliance. Labs & Teams: Directs the Healthy Brain Ageing and Repair Lab, focusing on translational research to address age-related neurological challenges through novel interventions.